These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17332908)

  • 61. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: a phenotypic assessment of NCCLS guidelines.
    Dressel DC; Tornatore-Reuscher MA; Boschman CR; Stosor V; Zembower T; Postelnick MJ; Noskin GA; Peterson LR
    Diagn Microbiol Infect Dis; 1999 Nov; 35(3):219-25. PubMed ID: 10626133
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of high-level aminoglycoside resistance in vancomycin-sensitive and vancomycin-resistant Enterococcus species.
    Yazgi H; Ertek M; Erol S; Ayyildiz A
    J Int Med Res; 2002; 30(5):529-34. PubMed ID: 12449524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.
    Assadian O; Askarian M; Stadler M; Shaghaghian S
    BMC Infect Dis; 2007 Jun; 7():52. PubMed ID: 17553129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.
    Tyrrell KL; Citron DM; Warren YA; Fernandez HT; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2728-31. PubMed ID: 16870765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative in vitro antimicrobial activity of tigecycline against clinical isolates of vancomycin-resistant enterococcus.
    Yemisen M; Demirel A; Mete B; Kaygusuz A; Mert A; Tabak F; Ozturk R
    Indian J Med Microbiol; 2009; 27(4):373-4. PubMed ID: 19736414
    [No Abstract]   [Full Text] [Related]  

  • 67. [Detection of vancomycin-resistant enterococci by a fully automated microbiology system, RAISUS].
    Nakasone I; Yamane N; Onaga S; Mishina M; Nishiyama N; Endo R; Iwawaki K
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2003; 14(2):151-8. PubMed ID: 15552837
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aminoglycoside resistance in enterococci.
    Chow JW
    Clin Infect Dis; 2000 Aug; 31(2):586-9. PubMed ID: 10987725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Flow cytometric determination of Enterococcus spp. susceptibility to four antimicrobial agents.
    Dolganiuc A; Pană M; Ghiţă M; Stăvaru C; Olinescu A
    Roum Arch Microbiol Immunol; 2001; 60(4):307-22. PubMed ID: 12561673
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model.
    Zelenitsky SA; Booker B; Laing N; Karlowsky JA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 1999 Mar; 43(3):592-7. PubMed ID: 10049272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
    Fritsche TR; Sader HS; Stillwell MG; Jones RN
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):440-6. PubMed ID: 19302928
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Significant increase in the isolation of glycopeptide-resistant enterococci from patients hospitalized in the transplant surgery ward in 2004-2005.
    Młynarczyk G; Grzybowska W; Młynarczyk A; Tyski S; Kawecki D; Łuczak M; Chmura A; Rowiński W
    Transplant Proc; 2007 Nov; 39(9):2883-5. PubMed ID: 18022008
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
    Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
    J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.
    Aslangul E; Massias L; Meulemans A; Chau F; Andremont A; Courvalin P; Fantin B; Ruimy R
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3615-21. PubMed ID: 17065620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.
    Brigante GR; Luzzaro FA; Pini B; Lombardi G; Sokeng G; Toniolo AQ
    BMC Microbiol; 2007 May; 7():46. PubMed ID: 17521437
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antimicrobial susceptibility of clinical isolates of enterococci.
    Hu BS; Fung CP; Lau YJ; Lin YH; Shi ZY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):111-5. PubMed ID: 11561575
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.